
     RDKit          3D

 22 22  0  0  0  0  0  0  0  0999 V2000
   -1.5534   -1.7903    0.0155 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4170   -0.8128    0.0001 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8301   -1.3454   -0.0118 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8744   -0.4975   -0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7522    0.8871   -0.0081 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0264    1.6899    0.0352 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7437    1.5233    1.2464 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7632    1.8082    2.6429 P   0  0  0  0  0  0  0  0  0  0  0  0
    3.9815    1.0797    3.4588 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4680    3.2860    2.6526 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8856    2.0631    3.8928 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.4409    1.4368    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2038    2.9207   -0.0228 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8947    3.5943    1.0803 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6733    5.0755    1.1259 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8275    5.4027    1.1741 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2995    5.6178    2.4269 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3453    5.8335   -0.0517 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0973    5.1085   -0.9045 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2293    7.0427   -0.2238 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6531    0.5594    0.0017 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9608    0.9594   -0.0047 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2 21  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5 12  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
  8 11  2  0
 12 13  1  0
 12 21  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 15 18  1  0
 18 19  1  0
 18 20  2  0
 21 22  1  0
M  END
>  <DRUGBANK_ID>  (1) 
DB04241

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
EXPT02361

>  <COMMON_NAME>  (1) 
N-Pyridoxyl-2-Methylalanine-5-Phosphate

$$$$
